The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.
Martínez MF, Martín XE, Alcelay LG, Flores JC, Valiente JM, Juanbeltz BI, Beldarraín MA, López JM, Gonzalez-Fernández MC, Salazar AM, Gandarias RB, Borda SI, Marqués NO, Amillano MB, Zabaleta MC, de Pancorbo MM.
Martínez MF, et al. Among authors: borda si.
BMC Neurosci. 2009 Sep 30;10:125. doi: 10.1186/1471-2202-10-125.
BMC Neurosci. 2009.
PMID: 19793392
Free PMC article.